市场调查报告书
商品编码
1410776
脑积水流器市场规模:按细分市场、份额、监管、报销、程序、预测至 2033 年Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
使用脑脊髓液 (CSF) 分流系统手术治疗脑积水是对儿童和成人患者进行的常见神经外科手术。分流器可以将多余的脑脊髓液 (CSF) 引流至身体的其他部位。
该报告深入探讨了全球脑积水分流器市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。
Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Hydrocephalus Shunts market for the year 2020 and beyond. Surgical treatment of hydrocephalus with a Cerebrospinl Fluid (CSF) Shunting system is a common neurosurgery procedure performed on both paediatric and adult patients. Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. In this segment, shunt valves and shunt catheters are considered.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Hydrocephalus Shunts and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Medtronic Plc, Integra LifeSciences Holdings Corp, Sophysa SA, Aesculap Inc, Spiegelberg GmbH & Co KG, Natus Medical Inc, Hpbio, G. Surgiwear Ltd and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable